— Know what they know.
Not Investment Advice

WST NYSE

West Pharmaceutical Services, Inc.
1W: +2.9% 1M: +6.6% 3M: +17.3% YTD: +43.0% 1Y: +28.6% 3Y: +7.6% 5Y: -2.3%
$398.20
+3.47 (+0.88%)
After Hours: $395.39 (-2.81, -0.71%)
Weekly Expected Move ±2.9%
$370 $381 $392 $403 $415
NYSE · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Buy · Power 71 · $27.8B mcap · 70M float · 0.940% daily turnover · Short 52% of daily vol
Credit Risk of going bust: lower than 93% of companies Debt: 1.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.34 (down 99.9%), West Pharmaceutical Services, Inc. would be worth roughly what it owes.
Total debt $312.1M against a stock market value of $27.78B.
Distance to default 16.41 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $166.5M (short-term plus half of long-term), stock volatility 31.4%; Altman Z 18.65. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$27.8B
52W Range223.83-397.16
Volume649,635
Avg Volume656,512
Beta1.12
Dividend$0.88
Analyst Ratings
14 Buy 2 Hold 1 Sell
Consensus Buy
Company Info
CEOMichel Lagarde
Employees10,800
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date1980-03-17
530 Herman O. West Drive
Exton, PA 19341-1147
US
610 594 2900
About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Recent Insider Trades

NameTypeSharesPriceDate
HAUGEN JANET BRUTSCH A-Award 44 — 2026-09-30
Favorite Annette F M-Exempt 2,524 $89.64 2026-09-15
Favorite Annette F S-Sale 2,524 $365.00 2026-09-15
Favorite Annette F M-Exempt 2,524 $89.64 2026-09-15
Favorite Annette F M-Exempt 2,500 $89.64 2026-09-14

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms